A patient’s age-related macular degeneration (AMD) at any stage should rise to a high level of importance for optometrists. Imaging is important to feel...
– IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across...
Bausch + Lomb announced new data from the National Eye Institute (NEI) 10-Year Follow-on Study Results of the Age-Related Eye Disease Study 2 (AREDS2),...
Amanda Legge, OD, of Wyomissing Optometric Center in Wyomissing, Pennsylvania, is grateful that her practice was an early adopter of dark adaptation technology nearly...